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Summary 
31P magnetic resonance spectroscopy provides tools to obtain bioenergetic data 
from skeletal muscle during exercise and recovery. The time constant (TC) of 
phosphocreatine (PCr) recovery is used as a measure of mitochondrial function. 
Muscle fibers are either slow twitch (ST) oxidative or fast twitch (FT) glycolytic 
fibers. ST fibers are generally recruited at lower force levels than FT fibers. 
However, at high contraction-velocities both types of fibers are recruited already at 
low force levels. This differential fiber type recruitment legitimates the distinction 
between exercise protocols of both low and increasing intensity at low contraction 
frequency (LE), and exercise protocols of high intensity and/or high contraction 
frequency (HE). Utilizing LE protocols, patients with mitochondrial 
encephalomyopathies (ME) and patients with migraine with aura (MA) have been 
demonstrated to differ from healthy volunteers (HV) with respect to TC values 
normalized for minimum pH reached during recovery (pHmin). Using an HE 
protocol it was not possible to detect the differences between controls and ME by 
means of 31P-MRS. This result might be explained by higher fractions of activated 
FT fibers and interindividual variations in muscle fiber type composition in HV. 
Thus, our results may imply that the differences detected with LE protocols could 
result from activation of higher fractions of FT fibers in patients, rather than from 
comparing whole muscle oxidative capacities. This new finding needs to be verified 
by measuring both LE and HE protocols for each subject in a follow-up study. 
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Abbreviations 
ATPtot, total ATP signal; AUCPCr, area under the curve of the PCr signal; CoQ10, 
Coenzyme Q10; FID, free induction decay; FT, fast twitch; HE, exercise of high 
intensity and/or high contraction frequency; HV, healthy volunteers; LE, exercise of 
low and increasing intensity at low contraction frequency; MA, migraine with aura; 
ME, mitochondrial encephalomyopathies; MELAS, Mitochondrial 
Encephalomyopathy, Lactic Acidosis, Stroke-like episodes syndrome; mtDNA, 
mitochondrial DNA; NARP, neuropathy, ataxia, retinitis pigmentosa syndrome; 
PCr, phosphocreatine; pHmin, minimum pH during recovery; Pi, free phosphate; 31P-
MRS, Phosphorus magnetic resonance spectroscopy; Ptot, sum of all recorded 
phosphorus signals; ST, slow twitch; TC, time constant. 
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1. Introduction 
Phosphorus magnetic resonance spectroscopy (31P-MRS) offers the possibility to 
study cell energy metabolism in vivo in various tissues. Due to the ability to 
perform exercise inside the MR scanner during data acquisition, 31P-MRS has been 
used to study various muscle disorders for almost 30 years, mitochondrial 
cytopathies being amongst them (1). 
Mitochondrial cytopathies are a diverse group of inherited and acquired disorders 
displaying inadequate energy production of the cell. Several syndromes linked to 
specific defects in the mitochondrial and nuclear genome have been identified. 
Mitochondrial encephalomyopathies (ME) are a subgroup of mitochondrial 
cytopathies in which both brain and muscle tissues are affected by the disease. In 
these patients migraine with aura is a common symptom. In general, migraine is a 
primary headache disorder which can be divided into the two subgroups: migraine 
with aura (MA) and migraine without aura. 
 
By means of 31P-MRS, ME and MA patients have been shown to differ from 
healthy controls with respect to recovery of the phosphocreatine (PCr) 
concentration in muscle tissue after exercise, which is represented by the time 
constant (TC) of the monoexponential recovery curve fit of the PCr peak as 
measured by 31P-MRS (2-6), called recovery time. This difference is reflecting 
mitochondrial defects in ME patients since it is well accepted that PCr recovery 
after exercise is solely governed by aerobic metabolism (7,8). 
To determine the maximal mitochondrial capacity to produce ATP, it has been 
pointed out that monitoring the recovery rate of PCr has the practical advantage that 
no measurement of force or performed work is required if the lowest pH value is 
reached during the first minute of recovery (termed minimum pH, pHmin) and 
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ranges between pH 6.75 and pH 6.95 (9-12). The known inhibitory influence of 
acidosis on creatine kinase elicits a direct linear relationship between recovery 
kinetics of PCr and pH values reached at the end of exercise. This relationship was 
claimed to be independent of either work output or the differential recruitment of 
glycolytic and oxidative fibers (12). Since the PCr signal recovery represents the 
average response of all fibers within sensitivity of the 31P-MRS measurement 
(11,13), all fibers need to be recruited equally and maximally which is well 
accepted to be verified by pHmin values below 6.95 (9). It was proposed that when 
monitoring PCr recovery exercise protocols, eliciting pH values below 6.75 should 
be avoided due to non-monoexponential recovery (10,14). This is in part supported 
by the finding that for pH values <6.50 monoexponential fits for PCr recovery and 
the resultant TC values are not accurate (15). 
However, these findings are in conflict with the reported substantial intersubject 
differences in the effect of acidosis on PCr recovery kinetics (16) and with the 
reported dependence of oxidative recovery on fiber recruitment (13), which in turn 
depends on the exercise protocol employed. 
 
Basically, muscle fibers are divided into two types, slow twitch (ST) fibers and fast 
twitch (FT) fibers. In general ST fibers are more oxidative with higher PCr 
resynthesis rates and they have lower anaerobic potential with less acidification in 
response to exercise than FT fibers. All muscle fiber types exhibit contraction-
velocity dependent recruitment behavior: the higher the contraction-velocity the 
lower the force levels at which they are activated; and at a given force level only 
motor units reaching their tonic threshold (defined as the minimal steady-force level 
maintaining a steady discharge of the motor unit) remain active during sustained 
contraction (17,18). ST fibers are recruited and stay active at lower force levels than 
FT fibers. Interindividually there are substantial variations in fiber type 
compositions of muscles (e.g. gastrocnemius muscle) (18). 
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During protocols of low intensity exercise and of increasing intensity exercise 
(ramp protocols) at low contraction frequency (LE) ST fibers are mainly recruited. 
With increasing workload at low contraction frequency the fraction of recruited FT 
fibers will increase. Still only part of them will remain active throughout a sustained 
contraction. Therefore, when PCr has dropped enough to assess its recovery rate in 
a LE protocol, full FT fiber activation, if at all, will have only been maintained for a 
comparatively short period and the PCr drop observed at the end of exercise will 
essentially result from ST fibers. Since FT fiber activation is mainly responsible for 
pH changes within the sensitivity volume of the receiving coil, pH will most likely 
have dropped less at a comparable PCr drop in LE than in protocols of high 
intensity and/or high contraction frequency exercises (HE). Hence, recovery rates 
after LE can be regarded as the oxidative capacity of ST fibers rather than as the 
oxidative capacity of the entire muscle under investigation. HE protocols on the 
other hand have a higher probability of activating all fiber types more or less 
equally right from the start of exercise and therefore show a more substantial drop 
in pH as a result of the overall greater FT fiber involvement (19). This hypothesis is 
supported by the fact that with HE protocols line broadening or even splitting of the 
resonance line of free phosphate (Pi) can be observed in 31P-MRS since the 
chemical shift of Pi is pH dependent. Pi splitting indicates two compartments with 
different pH; most likely ST and FT fibers, but is said to only occur at exhaustive 
work levels (20). Consequently, with HE protocols a PCr recovery rate composed 
of a mixture of recovery rates from ST and FT fibers will result, giving a better 
approximation of whole muscle oxidative capacity. The mixed answer regarding 
PCr recovery will strongly depend on the individual differential muscle fiber type 
composition. 
 
From the above considerations we hypothesize, in line with the findings mentioned 
above (13), that the dependence of differential fiber type recruitment on contraction 
speed and exercise intensity may produce different pHmin values and TC values 
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contingent on the employed exercise protocol in cooperation with the individual 
fiber type composition of the muscle under investigation. Thus, it might be further 
hypothesized that the difference in muscle fiber composition and recruitment as 
well as that in proton efflux rates - influencing the pHmin and known to be higher in 
ME patients (21) - between healthy volunteers (HV), MA and ME patients might 
mask the mitochondrial impairment in the patient groups when using a HE protocol 
to investigate muscle energy metabolism with in vivo 31P-MRS. Therefore it can be 
assumed that training, which changes muscle fiber type composition, might have an 
influence on the determined TC and pHmin values. In addition oxidative capacity has 
been revealed to decrease with age by 50% as was reported for elderly (65-80 
years) healthy subjects (22). 
 
Hence, our preliminary study intends to investigate the influence of the employed 
HE protocol and thus of fiber recruitment on PCr recovery rates and its interrelation 
to the minimal pH. A high contraction-velocity submaximal exercise protocol was 
implemented in order to fully activate all muscle fibers investigated and was 
applied to HV, ME patients and MA patients. By limiting the exercise duration to 
two minutes, pH was expected neither to fall too extensively nor to show 
compartmentation, since Pi splitting is indicative of strenuous exercise which can 
mimic disturbed mitochondrial function (23). Within two minutes sufficient blood 
flow and more importantly O2 delivery adjustments were allowed for (24-26) and 
tolerable loads were attained to show sufficient [PCr]-depletion to asses the TC, 
even for the clinically most severely affected ME patients. 
By comparing patient data to four different subgroups of HV (for details see section 
3.4. Data analysis) the influence of the confounding factors age, endurance training, 
strenuous exercise (as individually experienced) and pHmin 6.50 as lower limit for 
monoexponential PCr recovery were examined. 
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2. Methods 
2.1. Controls and patients 
25 healthy volunteers (HV), 11 migraine patients with aura (MA) and 9 patients 
with mitochondrial encephalomyopathy (ME) were investigated. After applying the 
quality criteria (explained in section 3.4. Data analysis) to the recorded data, 21 HV 
(12 females, 9 males; age: 18-64 years, average: 36.5 years), 5 MA (4 females, 1 
male; age: 18-37 years, average: 25.2 years) and 6 ME (3 females, 3 males; age: 28-
58 years, average: 43.7 years) were included into the analysis. All examinations 
were carried out according to the standards set by the latest revision of the 
Declaration of Helsinki and the study protocol was approved by the local ethics 
committee Zürich. Written informed consent to participate in this study was 
obtained in all cases. Migraine patients were diagnosed clinically according to the 
second edition of the International Classification of Headache Disorders (ICHD-II) 
(27). MA were free from headache attacks for at least ± 3 days around the date of 
examination and did not take any preventive or attack medication at that time. 
Diagnoses of mitochondrial cytopathies following international criteria were 
confirmed by either pathological findings and/or molecular genetic analysis. Four 
ME patients received daily oral Coenzyme Q10 (CoQ10) therapy (3 x 100 mg). Even 
under CoQ10 medication these four ME patients were clinically severely 
handicapped and three of them showed heavy impairment of muscular performance 
such as difficulties in building up the required pressure values and quick fatigue. 
Table 1 additionally lists other medications. Patient ME1 is carrier of the A3243G 
MELAS-mutation (Mitochondrial Encephalomyopathy, Lactic Acidosis, Stroke-like 
episodes syndrome) but apart from migraine headaches has not become clinically 
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manifest so far. Patient ME2 has the neuropathy, ataxia, retinitis pigmentosa 
(NARP) syndrome but had no additional muscular symptoms. 
 
 
 
 
ME diagnostic method mutation
clinical 
presentation CoQ10 other medication
1 Moleculargenetic mtDNA A3243G Asymptomatic no Oral contraceptive
2 Moleculargenetic mtDNA T8993G NARP yes Riboflavin
3 Moleculargenetic mtDNA C12346T  Optic neuropathy, 
Myopathy
yes Riboflavin
4 Moleculargenetic mtDNA T7679C (F32L)  Chorea syndrome yes Clonazepame
5 Bioptic  n.d. PEO,
Myopathy
no no
6 Bioptic  n.d. Cerebellar ataxia,
PEO,
Sensorineural 
deafness, 
Encephalopathy
yes Clonazepame,
Amitriptyline,
Citalopram,
Esomeprazole,
Alendronate,
Calcium carbonate, 
Cholecalciferol,
Perindoprile,
Ibuprofene,
Transdermal fentanyl
PEO:     Progressive external ophthalmoplegia
NARP:  Neuropathy, Ataxia, Retinitis pigmentosa
n.d.        not determined
Table 1
ME patients
 
Table 1: Methods used to validate the diagnosis of mitochondrial cytopathies, mutations 
found within the mitochondrial genome and medication at the time of investigation. 
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2.2. Exercise protocol 
In-magnet exercise was performed by pressing a pedal with the right foot. 
Resistance of the pedal was given by a blood pressure cuff initially filled up to 20 
mmHg. The subject being examined was asked to press the pedal at a frequency of 
80/min (28), triggered by a metronome, and to build up pressure values of 80 to 150 
mmHg with every tread. The plantar flexions were executed as rapidly as possible. 
A manometer served to control the pressure built up and the tread frequency. Oral 
feedback from the examinator was given to the subject. 
To avoid movement, the leg performing the exercise was fastened to the 
examination table just above the knee and the respective foot was attached to the 
pedal. The subject under examination held two straps, one in each hand in order to 
maintain the position on the examination table. 
 
 
 
2.3. 31P magnetic resonance spectroscopy 
31P magnetic resonance spectroscopy (31P-MRS) measurements were acquired on a 
whole-body 1.5 T MR system (Gyroscan Intera; Philips Healthcare, Best, the 
Netherlands) with a 10 cm diameter single-tuned circular transmit/receive surface 
coil positioned on the right calf muscle using a pulse-and-acquire technique. This 
resulted in a measured volume of roughly 260 ml in the shape of a hemisphere 
centered at the center of the coil. Excitation was carried out by a BIR-4 (29)  
(B1 insensitive rotation) pulse set to a flip angle of 40 degrees, using a receiver 
bandwidth of 1500 Hz. A time series of 100 free induction decays (FIDs) with 512 
samples per FID was recorded, using the following 10 min paradigm:  
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2 min (20 spectra) resting phase, 2 min (20 spectra) exercise phase, 6 min (60 
spectra) recovery phase. Each time step consisted of 4 averages with a repetition 
time of 1.5 s each. The shim volume was chosen to fit the anatomy of the subject 
and was roughly 80 ml (ranging from 35·35·60 mm3 = 73.5 ml to 35·40·65 mm3 = 
91 ml) (Figure 1). 
 
 
 
 
 
Figure 1: Planscan of the right lower leg demonstrating the chosen shim 
volume. The water phantom within the surface coil shows the center of the 
coil relative to the shim volume. A: anterior; L: left. 
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2.4. Data analysis 
Postprocessing of the spectra was done using the jMRUI v2.2. software package 
(30). Zero order phase correction was applied manually and a 9.8 Hz apodization 
filter and DC (direct current) correction using the last 150 points of the FID were 
executed on the time series. 
The AMARES algorithm (31) within jMRUI provided the means for quantification. 
Table 2 lists starting values for prior knowledge (32) on chemical shift, coupling 
constants and line shapes used for fitting. All signals were modelled as Lorentzian 
functions, and the amplitudes of the ATP doublets (α- and γ-ATP) and triplet (β-
ATP) were fitted with the fixed ratios 1:1 and 1:2:1 respectively. Soft constraints 
applied on chemical shift and line width are given in Table 3. 
 
 
 
peak frequency (Hz) line width (Hz)
α-ATP1 -203.4
α-ATP2 -185.0
β-ATP1 -428.0
β-ATP2 -420.5
β-ATP3 -403.7
γ-ATP1 -71.9
γ-ATP2 -58.1
PCr 0.0 9.1
Pi 123.7 9.1
6.1
9.1
Table 2
starting values for fitting
9.1
 
 
 Table 2: Starting values for fitting 
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peak frequency (Hz) line width (Hz)
α-ATP1 -211.9 – -193.9
α-ATP2 fs: +19.25
β-ATP1 fs: -11.47
β-ATP2 -429.1 – -411.0
β-ATP3 fs: +11.47
γ-ATP1 -80.1 – -62.0
γ-ATP2 fs: +15.86
PCr estimated 0.0 – 40.0
Pi 103.4 – 129.2 0.0 – 25.0
0.0 – 30.0
fs = fixed shift, j-coupling constant between the 
multiplet peaks
Table 3
prior knowledge - soft constraints for fitting
0.0 – 30.0
0.0 – 30.0
 
 
 Table 3: Prior knowledge for fitting 
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The manually applied zero order phase correction was fixed and the first order 
phase correction was kept to zero for quantification. Recovery of the PCr signal 
after exercise is described by the recovery time TC of the monoexponential function 
 ( )1 tTCs a d e −= ⋅ − ⋅ , (eq. 1) 
with: : calculated area under the curve of the PCr signal (AUCPCr) in a single spectrum 
at time t  
s
 : largest AUCPCr reached at the end of recovery (last spectrum) a
 : difference in % between  and the lowest AUCPCr at the beginning of recovery 
(first spectrum) 
d a
 : Euler’s number e
 : time in seconds after start of time series at the end of recording the respective 
single spectrum; discrete time steps of 6 seconds 
t
 
 
A best fit to the experimental points (9) was calculated by adjusting the variables 
TC,  and  by using the program Solver in Excel 2002 (SP-2, Microsoft 
Corporation, Redmond, WA). 
a d
 
Rigorous quality criteria were applied to the spectral time series. Single spectra 
within the time series were eliminated if all of the following three parameters 
deviated more than 5 % from their average over the whole time series: total ATP 
signal (sum of α-, β- and γ-ATP signals; ATPtot), the sum of all recorded signals 
(Ptot) (9,12) and the noise from the residue of the fitted signal. These three 
parameters should remain more or less constant throughout the entire experiment 
(12) if scan and fit are of high quality. Experiments with more than 10 % of the 
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single spectra in the recovery phase (6 spectra) not meeting these criteria were 
excluded from the study. Furthermore, experiments were excluded if the exercise 
and/or the recovery phase differed more than 6 s from the protocol owing to 
insufficient compliance of the investigated subject. Altogether the experimental 
data of 13 subjects (4 HV, 6 MA and 3 ME) were excluded from the study. pH 
values were calculated by jMRUI with the following modified Henderson-
Hasselbalch equation: 
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3.275log
5.685
obs
a
obs
pH pK δ δ
⎡ ⎤−= + ⎢ ⎥−⎣ ⎦
, (eq. 2) 
with: apK : = 6.73; negative common logarithm of the acid dissociation constant  aK
 obsδ : chemical shift observed between Pi and PCr in parts per million (ppm) 
 
 
Statistical analysis included checking the data for normal distribution, quantifying 
the differences between the groups with the effect size index δ (33) and testing for 
significance with ANOVA using the SPSS 17.0 software (SPSS Inc., Chicago, IL). 
Linear regression analysis (SPSS 17.0) was used to model the relationship between 
the TC value and pHmin. 
Patient data was then compared to four different subgroups of HV: (i) all, (ii) HV 
that were younger than 60 years (22), non-endurance trained (18) and who reached 
near steady state levels of PCr at the end of exercise (23), (iii) HV with pHmin above 
pH 6.50 (15), and (iv) HV of subgroup (ii) with pHmin above pH 6.50. 
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3. Results 
All patients and controls reached a sufficient extent of PCr depletion (>5% of 
resting [PCr]) to assess the rate of PCr resynthesis during recovery (14). Two ME 
patients were not able to reach the specified minimum pressure of 80 mmHg 
throughout the entire exercise and 4 ME, 2 MA and 7 HV did not work at the 
specified frequency of 80/min (range: 30-90/min) during the entire experiment. PCr 
depletion ranged from 12-87% (ME), 24-68% (MA) and 17-80% (HV). Visual 
inspection suggested near steady state values at the end of exercise in all ME, 4 of 5 
MA and 18 of 21 HV. ATP homeostasis and constancy of Ptot was maintained 
throughout the exercise protocol. During exercise Pi splitting in 1 MA patient and 4 
HV and Pi line broadening in all investigated subjects was observed. Pi line widths 
increased by factors ranging from 1.4-3.7 (ME), 2.0-3.0 (MA) and 1.5-3.6 (HV). 
These findings confirm the more likely submaximal than intense character of the 
employed exercise protocol (10,34). 
Typical single spectra of gastrocnemius muscle in the resting phase and at the end 
of exercise are shown in Figures 2a and 2b, respectively. The typical recovery 
pattern of the experimental PCr signal and the corresponding monoexponential fit 
are both displayed in Figure 3. 
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Figure 2: Typical single spectrum of gastrocnemius muscle: 
a) in the resting phase; 
b) at the end of exercise (last spectrum of the working muscle in the exercise phase); 
The bottom panel shows the original spectra before fitting with the jMRUI, v2.2. software 
package the center panel shows the estimate of the signals after fitting and the top panel 
displays the residues of the original signals after subtraction of the estimated signals. Signal 
intensities are in arbitrary units and have been scaled to a comparable level with respect to 
the ATP signals, which remain at a constant value throughout the entire examination. 
Frequencies are reported in parts per million (ppm). 
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Figure 3: Typical recovery pattern of the phosphocreatine (PCr) signal after exercise in a 
healthy volunteer. The experimental PCr signals are shown as black points at intervals of 6 
seconds. The calculated monoexponential fit of these recorded data points is indicated as 
black line. 
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Minimum pH ranged from pH 6.47-6.92 (ME), pH 6.42-6.95 (MA) and pH 6.39-
6.94 (HV), thus staying ≤ pH 6.95 in all cases. TC values extracted from the 
monoexponential fits plotted against pHmin are reported for all subjects in Figure 4a. 
All data, including patient data, lie within the 95% individual prediction interval of 
the regression line (y=−43·x+329; correlation coefficient r=−0.56) linking the TC 
values of PCr recovery to the pHmin values of the HV. Regression analysis after 
excluding seven HV data sets - three HV older than 60 years, one HV who did not 
reach near steady state level of PCr at the end of exercise and three HV who were 
endurance trained - resulted in two ME data sets lying outside of the 95% individual 
prediction interval of the regression line (y=−20·x+168, r=−0.40) and another ME 
data set at the border of the 95% individual prediction interval (Figure 4b). 
Additionally, taking into account the non-monoexponential recovery of PCr at pH 
<6.50 regression analysis was performed for data sets with pH >6.50. A correlation 
coefficient r of −0.77 was found for the HV after the above mentioned exclusions. 
Two ME and one MA data point lie outside of the 95% individual prediction 
interval of the regression line (y=−99·x+710). For comparison regression analysis 
was also performed for pHmin >6.50 without exclusion of any HV data sets. One HV 
and one ME data point lie outside of the 95% individual prediction interval of the 
regression line (y=−113·x+809, r=−0.71) (Figures 4c and 4d). Interestingly the 
three data points of the endurance trained HV are highly linearly correlated, 
r=−0.99, with the following equation for the regression line, y=−44·x+323 (plot not 
shown). 
 20
 
 
Figure 4: Phosphocreatine (PCr) recovery time plotted against minimum pH (pHmin) 
without exclusions in a) and c) compared to with exclusions in b) and d); equation for 
regression line and r value; 
a) 21 healthy volunteers (HV; open circles), 6 patients with mitochondrial 
encephalomyopathy (ME; black diamonds) and 5 migraine patients with aura (MA; 
black triangles); y=−43·x+329, r=−0.56; all recorded data lie within the 95% individual 
prediction interval of HV; 
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b) after exclusion of 7 HV: 3 older than 60 years, 1 that did not reach near steady state 
levels of PCr at the end of exercise (as 2 of the HV older than 60 years also did not) 
and 3 that were endurance trained: 14 HV, 6 ME, 5 MA; y=−20·x+168, r=−0.40; 2 ME 
data sets lying outside and 1 ME data set lying at the border of the 95% individual 
prediction interval of HV; 
c) pHmin >6.50: 15 HV, 5 ME, 4 MA; y=−113·x+809, r=−0.71; 1 HV and 1 ME data point 
lie outside of the 95% individual prediction interval of HV; 
d) pHmin >6.50: after exclusion of 4 HV: 1 older than 60 years, 1 that did not reach near 
steady state levels of PCr at the end of exercise and 2 that were endurance trained: 11 
HV, 5 ME, 4 MA; y=−99·x+710, r=−0.77; 2 ME and 1 MA data point lie outside of the 
95% individual prediction interval of HV; 
The PCr recovery time is represented by the time constant (TC) of the monoexponential 
function best fitting the experimental points and is plotted as a function of pHmin which 
refers to the lowest value of cytosolic pH reached during the first minute of recovery after 
exercise. The central straight line in each plot illustrates the linear regression linking the TC 
values to the pHmin values of the HV and the two outer lines delimit the corresponding 95% 
individual prediction interval. 
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The 31P-MRS spectra of resting gastrocnemius muscle were examined for 
differences between groups in the ratios of Pi/PCr, which allows an estimate of the 
cytosolic free [ADP], PCr/ATP, and Pi/ATP. All three of these ratios represent an 
indicator of the energy status of the examined muscle tissue and have been reported 
to differ between groups of ME and HV by different investigators (10,21,28,35-38). 
In accordance with results of other research groups (1,3,5,10,39-43) the analyzed 
ratios in this study were not significantly different (Bonferroni adjusted p-values 
between 0.597 and 1.0) between the three groups (Figure 5a, 5b and 5c). 
 23
  
 
 
 
Figure 5: Scatterplots of resting gastrocnemius values of: 
a) Pi/PCr-ratio; 
b) PCr/ATP-ratio; 
c) Pi/ATP-ratio; 
for 21 healthy volunteers (HV; open circles), 6 patients with mitochondrial 
encephalomyopathy (ME; black diamonds) and 5 migraine patients with aura (MA; black 
triangles). 
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4. Discussion 
To date it is believed that two parameters, the TC of PCr recovery and pHmin, give 
full information on the muscle’s oxidative capacity: a pHmin below 6.95 is reported 
to indicate sufficient muscular activation to assess the full mitochondrial capacity to 
synthesize ATP by measuring TC (9,14), since it is well accepted that recovery after 
exercise is solely governed by aerobic metabolism (7,8). In our study, all patients 
and controls showed an adequate drop in [PCr] during exercise to reliably extract 
the TC of PCr recovery from the acquired data (14). Minimum pH was below or 
equal pH 6.95 in all volunteers and patients. However, as hypothesized in the 
introduction the employed HE protocol could not demonstrate the previously 
reported (2-6) differences between the investigated groups of ME, MA and HV 
(Figure 4a) although this study complied with the above requirements on pHmin and 
PCr drop. More precisely, according to those reports it was anticipated that all ME 
and at least some MA data points would come to lie outside the 95% individual 
prediction interval of the linear regression analysis of TC as a function of pHmin. In 
this study all patients lie inside the 95% prediction interval when it is derived from 
all HV. 
 
The direct linear relationship between recovery kinetics of PCr and pH values 
reached at the end of exercise was claimed to be independent of either work output 
or the differential recruitment of glycolytic and oxidative fibers during low 
frequency isotonic exercise (of  LE type) by investigating the forearm flexors of 
healthy subjects (12). By employing an isokinetic low frequency ramp exercise 
protocol (also of LE type) the linear relationship between TC and pHmin could also 
be demonstrated for calf muscles in HV (y=−46·x+342, r=−0.92) (9). 
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With r=−0.92 a clearly different correlation coefficient was found by this latter 
group in comparison to this study (HE type) with r=−0.56. After excluding HV for 
reasons of age above 60 years, strenuous exercise as individually experienced, 
endurance training and pHmin values <6.50, the correlation coefficient in our control 
group data improved to give good linear correlation with r=−0.77 and a regression 
line equation of y=−99·x+710. 
This improvement of linear correlation is in line with the hypotheses developed in 
the introduction. The following paragraphs discuss these aforementioned possible 
reasons behind this finding and possible explanations for the relationship between 
HV and patient data found in this study: (i) a greater spread in the control group due 
to age and training effects on muscle fiber composition and oxidative capacity, (ii) 
non-monoexponential PCr recovery for pH <6.50, (iii) differential muscle fiber type 
recruitment in HE and LE protocols and (iv) additional compensation mechanisms 
in ME and MA patients. 
 
(i) By comparing younger adults (25 to 48 years) with elderly subjects (65 to 80 
years), oxidative capacity has been revealed to decrease with age by up to 50% 
(22). Looking at our data the three HV older than 60 years had strikingly higher TC 
values compared to the younger HV with comparable pHmin. In addition two of the 
three HV older than 60 years did not reach near steady state PCr levels during 
exercise, had pHmin <6.50 and featured Pi splitting during exercise and recovery. 
Not reaching near steady state PCr levels during the employed HE protocol as well 
as Pi splitting is indicative of strenuous exercise as individually experienced (20). 
Such strenuous exercise in healthy subjects can mimic disturbed mitochondrial 
function (23), which is well in line with our data. A third HV (aged 18) did not 
reach near steady state PCr levels, also showed a remarkably higher TC value than 
expected and Pi splitting. We could not identify any reason for this behavior. 
It is known that endurance training influences muscular oxidative capacity (44-46). 
Endurance trained have considerably higher fractions of ST fibers (18) and 
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therefore demonstrate relations between pHmin and TC values in our HE protocol as 
do sedentary HV in LE protocols, where mainly ST fibers are activated. This is 
demonstrated by good agreement of regression line equations for the endurance 
trained in our study (y=−44·x+323, r=−0.99) and sedentary healthy controls in the 
above mentioned isokinetic low frequency ramp exercise protocol study 
(y=−46·x+342, r=−0.92) (9). Three HV performed regular endurance training, of 
which one showed a pHmin <6.50 and a split Pi peak during exercise. 
 
(ii) As stated in the introduction it was demonstrated that monoexponential fits of 
PCr recovery and the resultant TC values are not accurate for pH values <6.50 (15). 
 
(iii) In contrast to LE protocols HE protocols have a higher probability of activating 
all fiber types more or less equally right from the start of exercise and therefore 
have a PCr recovery rate composed of a mixture of recovery rates from ST and FT 
fibers. Then the lower absolute r values found in this study compared to r=−0.92 of 
the above mentioned isokinetic low frequency ramp exercise protocol (LE; mainly 
ST fiber recovery) possibly reflect the interindividual variations in muscle fiber 
type composition detected with HE protocols. It is therefore reasonable to assume 
that the linear correlation of pHmin and TC is worsened and the slope of the 
regression line changes with diverse fractions of FT fibers involved in the PCr 
recovery. Hence both are strongly dependent on the individual fiber type 
compositions of the members of the investigated groups. 
Only at pHmin >6.50 and when excluding the one HV >60 years of age and the two 
endurance trained HV is our control group homogeneous enough to give a high 
linear correlation (r=−0.77) and with it a 95% individual prediction interval, which 
does not contain two of five ME patients and one of three MA patients. 
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(iv) It was deduced earlier that HV display higher TC values in recovery from HE 
protocols than from LE protocols, whereas the difference between TC values for 
HE and LE protocols in ME patients is supposedly comparatively small. In order to 
comply with the demands of either exercise protocol ME patients are presumed to 
be forced to recruit FT fibers at an earlier stage than HV in any protocol and 
therefore have a lower dependency of TC values on exercise protocol because of a 
more or less exercise independent mixture of recovery rates from ST and FT fibers. 
In both protocol types ME patients should remain at higher pH levels than the HV 
(as reported previously (21) and shown for our HE protocol in Figure 4a) as a result 
of their increased proton elimination capacity; although anaerobic glycolysis is 
more active than in HV. Added up, these findings suggest that ME have 
approximately the same TC and pHmin values in LE and HE protocols, whereas HV 
do not. Thereafter, HV have lower TC and higher pHmin values in LE protocols than 
in HE protocols, which leads to the hypothesized masking of the mitochondrial 
impairment in ME patients with HE protocols. Altogether these features might 
explain the behavior of the ME patients data sets investigated in this study, since it 
has been reported, that by employing a ramp exercise protocol it should be possible 
to discriminate healthy and diseased muscles (with respect to functionality of 
mitochondria oxidation) with 100% specificity and sensibility even in the absence 
of any clinical symptoms and signs (4). 
Mitochondrial cytopathies do not affect all muscles equally due to the pattern of 
inheritance or acquirement as well as propagation of the nuclear DNA and 
mitochondrial DNA (mtDNA) defects, respectively. Since there was no clinical 
indication no muscle biopsies of the investigated calf muscles were performed on 
ME patients within the framework of this study. Therefore, certainty of 
investigating muscles with defect mitochondria was not granted. Clinical symptoms 
of leg muscle weakness were the only available signs indicating infestation with 
defect mitochondria of the calf muscle. The two ME patients (ME4 and ME6, see 
also Table 1) identified in Figure 4d are both clinically severely affected with 
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severe involvement of the legs. Two of the three other ME patients (ME1 and ME2) 
either do not have any clinical symptoms apart from migraine headache (ME1) or 
do not have any muscle symptoms (ME2). In addition, ME1 regularly performed 
aerobic training. It is surprising that ME3, who shows heavy weakness in leg 
muscles, has her data point lying on the regression line for the HV in Figure 4d. 
ME3 had difficulties in reaching the specified workload, worked at a frequency of 
40/min but showed a comparatively large drop in PCr (48% of the resting value) at 
that workload. ME4, ME6, ME2, and ME3 had been on CoQ10 therapy for more 
than 6 months at the time of investigation. Many studies have been performed on 
the effect of CoQ10 in mitochondrial cytopathies, some of them using 31P-MRS, 
reporting controversial results concerning the effectiveness of CoQ10 in improving 
PCr recovery rates after exercise (6,28,47). One of those 31P-MRS studies employed 
a ramp exercise protocol and plotted TC values as a function of pHmin and compared 
patients to HV. All ten patients were well outside the 95% confindence interval of 
the HV before CoQ10 treatment and all but two were still outside after CoQ10 
treatment (6). ME4 and ME6 data points support the latter finding. ME3 could be 
like one of the two patients who showed normal PCr recovery after CoQ10 therapy 
or like the single therapy responder in one of the other reports, where a HE protocol 
(80 contractions/min) was used (28).  
It had been demonstrated that some MA patients differ from healthy controls in 
their PCr recovery rates (2,5) or that some come to lie outside the normal range of 
TC values as functions of end exercise pH (3). All three cited studies employed 
steady state exercise protocols with stepwise increasing workloads (of LE type). 
MA patients do not feature increased proton efflux, as do ME patients, but it has 
been pointed out that they have a reduction in glycolytic flux and therefore less 
acidification at comparable PCr breakdown values (5). Using the same 
argumentation as above for ME patients, in MA patients this reduced glycolysis 
increases the fraction of activated FT fibers in LE protocols, since more FT fibers 
are needed to fulfill the same requirements imposed by the exercise protocol. 
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Consequently, LE protocols generate TC values composed of a mixture of ST and 
FT PCr recovery times in MA patients. In HE protocols the differences between 
MA and HV would therefore disappear in consequence of the more similar mixture 
of activated ST and FT fibers between groups. 
 
For completeness, differences in resting values between groups were looked for. 
The ratios of Pi/PCr, PCr/ATP, and Pi/ATP have been reported to differ between 
groups of ME and HV by different research groups (10,21,28,35-38). In line with 
results of other investigators (1,3,5,10,39-43) the analyzed ratios in this study were 
not significantly different between the three groups (Figure 5a, 5b and 5c). 
 
In conclusion, it was possible to emphasise the importance of exercise protocols and 
differential fiber recruitment when investigating diseased in comparison to healthy 
muscles. It seems possible that the differences between groups of healthy controls 
and ME patients observed in previous studies employing LE protocols on 
gastrocnemius muscle result from activation of higher fractions of FT fibers in 
muscles of ME patients, rather than from truly comparing whole muscle oxidative 
capacities. Thus, when employing HE protocols, higher fractions of activated FT 
fibers and the interindividual variations in muscle fiber type composition in HV 
could be masking the differences between controls and ME patients, which can be 
detected with LE protocols. Additionally, the differential fiber recruitment in 
dependence on exercise protocols challenges the notion of absolute workload 
independence of PCr recovery rates. All these findings need to be verified in 
follow-up studies where subjects have to be investigated with both LE and HE 
protocols and where exercise intensity has to be recorded. 
Our study confirmed the confounding factors age, endurance training, strenuous 
exercise (as individually experienced) and pHmin 6.50 as lower limit for 
monoexponential PCr recovery and therefore requires the follow-up studies to 
match groups for age, sex and level of training and to exclude data sets with pHmin 
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<6.50. Also, for certainty of investigating diseased/unaffected muscle in ME 
patients, non-ME patients respectively, biopsies of the investigated muscle need to 
be performed on each study participant. 
 
Outlook 
In order to fulfill the above mentioned requirements for follow-up studies, our 
group has developed a MR compatible dynamometer for the measurement of 
muscular force during isometric contractions of the plantarflexor muscles against a 
pedal which allows conducting HE as well as LE protocols. Visual feedback of the 
measured force to the subject under investigation is granted, which is expected to 
increase the compliance of study participants with the protocol requirements. We 
are looking forward on testing the hypotheses developed above with our new 
ergometer, paying attention to the requirements identified by our preliminary study. 
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